Valeant Pharmaceuticals

Congress: Drugmakers Planned Price Hikes to Boost Profits

Two drugmakers have made a practice of buying and then dramatically hiking the prices of low-cost drugs given to patients with life-threatening conditions including heart disease, AIDS and cancer, according ...

February 2, 2016BY The Associated Press
Valeant Says It Will Survive Scrutiny Over Business Practices

MONTREAL—The CEO of Valeant Pharmaceuticals vowed on Tuesday, Nov. 10, to listen more to patients and critics as ...

November 11, 2015BY The Canadian Press
Valeant Shares Tumble as Report Questions Company Finances

Valeant Pharmaceuticals stock plunged Wednesday after Citron Research compared the Canadian pharmaceutical company to the collapsed energy giant ...

October 21, 2015BY The Associated Press

TOP NEWS